Intrinsic Value of S&P & Nasdaq Contact Us

Cannonau Corp. CNNC OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
70/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cannonau Corp. (CNNC) reported total assets of $0.00 and total liabilities of $0.00 for quarter ending 2024-03-31, resulting in total equity of $0.00.

The company held $0.00 in cash and short-term investments. Total debt stood at $0.00.

Criteria supported by this page:

  • HEALTH (83/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (50/100) — Total assets $0.00 and equity $0.00 support the company's competitive scale

Overall SharesGrow Score: 66/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
70/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
N/A
No coverage
PAST
25/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
50/100
Proven by this page
GROWTH
90/100
→ Income
INCOME
N/A
No coverage
Cannonau Corp. Balance Sheet History
Metric Q1 FY2024 Q4 FY2023 Q3 FY2023 Q2 FY2023
Total Assets $0.00$0.00$8.93K$8.99K
Total Liabilities $0.00$0.00$371.56K$365.62K
Total Debt $0.00$0.00$353.18K$335.05K
Cash & Investments $0.00$0.00$61.00$117.00
Total Stockholders Equity $0.00$0.00$-362.63K$-356.64K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message